quantification analysis of dot blot assays for human immunodeficiency virus type 1 and 2 antibodies

Authors

m. ravanshad department of virology, faculty of medical sciences, tarbiat modarres university, tehran, iran

f. sabahi department of virology, faculty of medical sciences, tarbiat modarres university, tehran, iran

f. mahboudi biotechnology research center, pasture institute of iran, tehran, iran

abstract

objective dot blot (db) assay provides highly specific results, but usually not reliable for quantification of antibody production. the need for a more objective db assay to provide a better definition of the immune status, against hiv antigens, promoted this study to be done to develop a quantitative db assay. material and methods dot blot (db) strips for antibodies directed to human immunodeficiency virus (hiv) type 1 and 2 were analyzed by a video densitometer. this method was used to quantify the antibody response to different hiv proteins in infected patients. in order to increase reproducibility, reagents and protocols were accurately standardized and internal controls were added. in the first format, an internal control band consisting of human igg was added to each dot to minimize the effects of band intensity variation. in the second format, antibody concentrations were calculated from the ratio of the densities produced by test sera and by positive and negative standard sera. results the sera under scrutiny were also examined by standard enzyme-linked immunosorbent assay (elisa) and the obtained results were compared with those of the corresponding db. a statistically significant positive correlation was found between the results obtained with the two methods, and this was especially evident when elisa titers were compared to corrected db values (p = 0.001). conclusion densitometric analysis of db assays led to quantify the antibodies against hiv-1 and 2 gag and env proteins and might be useful to investigate possible humoral immune correlates of production in hiv vaccine studies and antibody production in the early phase of infection.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Quantification Analysis of Dot Blot Assays for Human Immunodeficiency Virus Type 1 and 2 Antibodies

Objective Dot Blot (DB) assay provides highly specific results, but usually not reliable for quantification of antibody production. The need for a more objective DB assay to provide a better definition of the immune status, against HIV antigens, promoted this study to be done to develop a quantitative DB assay. Material and Methods Dot blot (DB) strips for antibodies directed to human immuno...

full text

Quantification Analysis of Dot Blot Assays for Human Immunodeficiency Virus Type 1 and 2 Antibodies

Objective Dot Blot (DB) assay provides highly specific results, but usually is not reliable for quantification of antibody production. The need for a more objective DB assay to provide a better definition of the immune status, against HIV antigens, promoted this study to develop a quantitative DB assay. Materials and Methods Dot blot (DB) strips for antibodies, directed to human immunodeficienc...

full text

Dot-Blot Enzyme Immunoassay for the Detection of Bovine Herpes Virus-1(BHV-1) Antibodies

Various detection methods have been developed for serological monitoring BHV1, an alphaherpesvirus and the cause of the respiratory disease, abortion, conjectivitis and other clinical forms of disease complex in cattle, in different laboratories throughout the world. The objective of this study was to develop and evaluate dot-blot enzyme immunoassay as a proper and inexpensive method for detect...

full text

Resistance mechanism of human immunodeficiency virus type-1 protease to inhibitors: A molecular dynamic approach

Human immunodeficiency virus type 1 (HIV-1) protease inhibitors comprise an important class of drugs used in HIV treatments. However, mutations of protease genes accelerated by low fidelity of reverse transcriptase yield drug resistant mutants of reduced affinities for the inhibitors. This problem is considered to be a serious barrier against HIV treatment for the foreseeable future. In this st...

full text

Human immunodeficiency virus type 2.

IP: 54.70.40.11 On: Mon, 19 Feb 2018 23:13:22 Journal of General Virology (2002), 83, 1253–1265. Printed in Great Britain . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ....

full text

application of sybr-green real time rt-pcr for quantification of human immunodeficiency virus type-1 (hiv-1) and comparison with cobas amplicor test

objective: in this study, a sybr green real-time rt-pcr assay for quantification of hiv-1 viral rna was developed. materials and methods: this assay was performed based on amplification of the pol region of hiv-1 and product analysis by an abi 7500 system. we quantified hiv-1 viral load in 26 seropositive patients by this system and the data were subsequently compared with results obtained wit...

full text

My Resources

Save resource for easier access later


Journal title:
iranian journal of basic medical sciences

جلد ۱۰، شماره ۲، صفحات ۱۳۲-۱۳۸

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023